Literature DB >> 15278863

Ex vivo produced human conjunctiva and oral mucosa equivalents grown in a serum-free culture system.

Michiko Yoshizawa1, Stephen E Feinberg, Cynthia L Marcelo, Victor M Elner.   

Abstract

PURPOSE: We sought to develop full-thickness ex vivo produced human conjunctiva and oral mucosa equivalents using a serum-free culture system without a feeder layer and to compare conjunctiva and oral mucosa equivalents to assess their suitability as graft materials for eyelid reconstruction.
MATERIALS AND METHODS: Human conjunctival and oral mucosal keratinocytes were cultured, expanded, and seeded onto AlloDerm (LifeCell Corp, Branchburg, NJ), a cadaveric, acellular dermis, to produce ex vivo produced full-thickness mucosa equivalents. Histology of equivalents and their expression of immunoreactive Ki-67, a proliferation marker, and GLUT1, a membrane antigen seen in barrier tissues, were examined at 4, 11, and 18 days after seeding onto AlloDerm.
RESULTS: Progressive epithelial stratification was observed on day 4, 11, and 18 conjunctiva and oral mucosa equivalents. Ki-67 immunoreactivity progressively increased with cultured time in both types of equivalent, indicating the continued presence of actively proliferating cells. GLUT1 immunoreactivity, concentrated in the basal keratinocytes of stratified epithelia of both types of equivalents, mimicked native tissue and indicated a high glycolytic state of the basal cells.
CONCLUSIONS: Conjunctival and oral mucosal equivalents are similar to native tissue and demonstrate high proliferative and glycolytic states. Due to the similarity to conjunctiva, oral mucosal equivalents may be useful for eyelid reconstruction. Their advantages for surgical reconstruction include 1) ease of obtaining autogenous oral epithelium for expansion in vitro without the possibility of contaminating cellular- or serum-borne biologic agents, 2) growth of intact, confluent epithelia on rigid, transplantable human allogeneic dermis that may be surgically transplanted, and 3) reduced donor site morbidity and surgical time.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15278863     DOI: 10.1016/j.joms.2004.02.010

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  7 in total

Review 1.  Epithelial stem cells of the eye surface.

Authors:  R P Revoltella; S Papini; A Rosellini; M Michelini
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

Review 2.  Tissue engineering of oral mucosa: a shared concept with skin.

Authors:  Beste Kinikoglu; Odile Damour; Vasif Hasirci
Journal:  J Artif Organs       Date:  2014-10-18       Impact factor: 1.731

3.  Intraoral grafting of tissue-engineered human oral mucosa.

Authors:  Kenji Izumi; Rodrigo F Neiva; Stephen E Feinberg
Journal:  Int J Oral Maxillofac Implants       Date:  2013 Sep-Oct       Impact factor: 2.804

4.  Characterization of squamous cell carcinoma in an organotypic culture via subsurface non-linear optical molecular imaging.

Authors:  Christina S Scanlon; Elizabeth A Van Tubergen; Leng-Chun Chen; Sakib F Elahi; Shiuhyang Kuo; Stephen Feinberg; Mary-Ann Mycek; Nisha J D'Silva
Journal:  Exp Biol Med (Maywood)       Date:  2013-10-01

Review 5.  Concise Review: Comparison of Culture Membranes Used for Tissue Engineered Conjunctival Epithelial Equivalents.

Authors:  Jon Roger Eidet; Darlene A Dartt; Tor Paaske Utheim
Journal:  J Funct Biomater       Date:  2015-12-11

6.  Surgical Outcomes of Porcine Acellular Dermis Graft in Anophthalmic Socket: Comparison with Oral Mucosa Graft.

Authors:  Livia Teo; Young Jun Woo; Dong Kyu Kim; Chang Yeom Kim; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2017-02-02

7.  An engineered human conjunctival-like tissue to study ocular surface inflammatory diseases.

Authors:  Laura García-Posadas; Laura Soriano-Romaní; Antonio López-García; Yolanda Diebold
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.